Home2162 • HKG
add
Keymed Biosciences Inc
Nakaraang pagsara
$45.70
Sakop ng araw
$44.20 - $45.80
Sakop ng taon
$27.05 - $51.35
Market cap
12.48B HKD
Average na Volume
4.02M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 186.72M | 1,284.61% |
Gastos sa pagpapatakbo | 298.81M | 35.17% |
Net na kita | -89.25M | 56.07% |
Net profit margin | -47.80 | 96.83% |
Kita sa bawat share | — | — |
EBITDA | -97.64M | 51.65% |
Aktuwal na % ng binabayarang buwis | -0.10% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.16B | -20.73% |
Kabuuang asset | 3.77B | -3.00% |
Kabuuang sagutin | 1.29B | 44.11% |
Kabuuang equity | 2.48B | — |
Natitirang share | 275.60M | — |
Presyo para makapag-book | 5.09 | — |
Return on assets | -7.72% | — |
Return on capital | -9.01% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -89.25M | 56.07% |
Cash mula sa mga operasyon | -211.86M | -23.44% |
Cash mula sa pag-invest | 53.78M | 350.02% |
Cash mula sa financing | 9.99M | -73.74% |
Net change in cash | -145.75M | -10.35% |
Malayang cash flow | -96.66M | 43.81% |
Tungkol
CEO
Itinatag
Set 2016
Website
Mga Empleyado
1,258
